A case of gemcitabine-induced thrombotic microangiopathy in a urothelial tumor patient with a single kidney
Thrombotic microangiopathy (TMA) is a rare complication of gemcitabine treatment. A 55-year-old man with a history of urothelial cancer underwent right ureteronephrectomy and palliative chemotherapy. The patient presented with dyspnea, generalized edema with foamy urine, and new-onset hypertension w...
Saved in:
Main Authors: | Hyunjin Ryu (Author), Eunjeong Kang (Author), Seokwoo Park (Author), Sehoon Park (Author), Kyoungbun Lee (Author), Kwon Wook Joo (Author), Hajeong Lee (Author) |
---|---|
Format: | Book |
Published: |
The Korean Society of Nephrology,
2015-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Thrombotic Microangiopathy Caused by Gemcitabine in a Patient with Duodenal Cancer
by: Jeyachandran Dhanapriya, et al.
Published: (2017) -
Thrombotic microangiopathy resulting from neglected blood pressure control
by: Jeong Sang Ku, et al.
Published: (2014) -
COVID-19 and thrombotic microangiopathy
by: E. V. Sluhanchuk, et al.
Published: (2022) -
Transplant-associated thrombotic microangiopathy
by: Tomasz Jarmoliński
Published: (2021) -
A new pathological perspective on thrombotic microangiopathy
by: Yong-Jin Kim
Published: (2022)